The store will not work correctly when cookies are disabled.
5-tert-Butyl-N-(4-fluorophenyl)pyrazine-2-carboxamide
ID: ALA496552
PubChem CID: 24881804
Max Phase: Preclinical
Molecular Formula: C15H16FN3O
Molecular Weight: 273.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1cnc(C(=O)Nc2ccc(F)cc2)cn1
Standard InChI: InChI=1S/C15H16FN3O/c1-15(2,3)13-9-17-12(8-18-13)14(20)19-11-6-4-10(16)5-7-11/h4-9H,1-3H3,(H,19,20)
Standard InChI Key: AFWVVRZUDBEFJW-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
10.1194 -15.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1182 -16.0732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8331 -16.4860 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5495 -16.0727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5466 -15.2422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8313 -14.8330 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2596 -14.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9756 -15.2368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2564 -14.0020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6885 -14.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4029 -15.2348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1153 -14.8203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1127 -13.9944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3916 -13.5848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6822 -14.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4034 -16.4851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6833 -16.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8122 -17.2017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9964 -15.7675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8250 -13.5783 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8 10 1 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
2 16 1 0
7 8 1 0
16 17 1 0
16 18 1 0
7 9 2 0
16 19 1 0
4 5 1 0
13 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.31 | Molecular Weight (Monoisotopic): 273.1277 | AlogP: 3.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.09 | CX LogD: 3.09 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.91 | Np Likeness Score: -1.86 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |